Neuraxis Statistics
NYSE: NRXSHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
6.94+0.14 (+2.06%)
Market open · Delayed 15 min · as of Oct 9, 1:42 PM ET
Neuraxis by the numbers
Neuraxis has a market capitalization of $87.1 million based on 12.56M shares outstanding. With trailing EPS of $-0.78, Neuraxis is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.6% above its 50-day average and 7.8% above its 200-day average.
Average daily trading volume is 107.27K shares, or about $743,883 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NRXS valuation vs. peer median
| Metric | NRXS | Peer median | Difference |
|---|---|---|---|
| Market cap | $87.09M | $81.56M | +7% |
| Avg. volume | 107.27K | 119.63K | -10% |
Peer median across 8 companies: ECOR, OM, HYPR, STXS, VANI, POCI, QTI, ITOC.
Valuation
- Market cap
- $87.09M
- EPS (TTM)
- $-0.78
- Shares outstanding
- 12.56M
Price and trading
- Previous close
- 6.80
- Open
- 6.96
- Day range
- 6.79 – 7.05
- 52-week range
- 2.21 – 9.33
- 52-week change
- +116.29%
- Beta
- —
- Volume
- 40.19K
- Average volume
- 107.27K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 87.09M
- Forward Pe
- -25.69
- Eps
- -0.78
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 9.33
- Week52 Low
- 2.21
- Avg Volume
- 107.27K
- Shares Outstanding
- 12.56M
- Ma50
- 6.57
- Ma200
- 6.43
- Pct From52w High
- -25.67%
- Pct From52w Low
- 213.80%